Form 8-K - Current report:
SEC Accession No. 0001144204-12-067055
Filing Date
2012-12-10
Accepted
2012-12-10 06:01:42
Documents
2
Period of Report
2012-12-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v330013_8-k.htm 8-K 15960
2 EXHIBIT 99.1 v330013_ex99-1.htm EX-99.1 9717
  Complete submission text file 0001144204-12-067055.txt   27006
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 121251477
SIC: 2836 Biological Products, (No Diagnostic Substances)